berberine has been researched along with astaxanthine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cicero, AF; Rovati, LC; Setnikar, I | 1 |
| Cacciotti, L; Caminiti, G; Grieco, F; Iaia, L; Marazzi, G; Massaro, R; Pelliccia, F; Rosano, G; Sposato, B; Volterrani, M | 1 |
| Brea, A; De Castro-Orós, I; Mozas, P; Pocoví, M; Puzo, J; Solà, R; Valls, RM | 1 |
| Andreozzi, S; Dalmaso, S; Fabrizio, A; Marchitto, N; Mauti, M; Raimondi, G; Sindona, F | 1 |
| Bellentani, S; Cicero, AFG; Colletti, A | 1 |
| Avila-Carrasco, L; Díaz-Avila, DL; García-Mayorga, EA; Garza-Veloz, I; González-Mateo, GT; Martinez-Fierro, ML | 1 |
2 review(s) available for berberine and astaxanthine
| Article | Year |
|---|---|
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Topics: Antioxidants; Berberine; Curcumin; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Observational Studies as Topic; Plant Extracts; Probiotics; Randomized Controlled Trials as Topic; Resveratrol; Salvia miltiorrhiza; Silymarin; Ubiquinone; Vitamin D; Vitamin E; Xanthophylls | 2018 |
Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease.
Topics: Antioxidants; Berberine; Beta vulgaris; Betalains; Biological Products; Catechin; Curcumin; Disulfides; Flavonoids; Humans; Isothiocyanates; Kidney; Kidney Diseases; Plant Extracts; Pomegranate; Protective Agents; Resveratrol; Sulfinic Acids; Sulfoxides; Xanthophylls | 2021 |
2 trial(s) available for berberine and astaxanthine
| Article | Year |
|---|---|
Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
Topics: Anticholesteremic Agents; Berberine; Cholesterol; Dietary Supplements; Drug Combinations; Dyslipidemias; Fatty Alcohols; Female; Folic Acid; Humans; Lipids; Lipoproteins; Liver Function Tests; Male; Middle Aged; Single-Blind Method; Xanthophylls | 2007 |
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Berberine; Biological Products; Blood Glucose; Cholesterol; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Medication Adherence; Prospective Studies; Single-Blind Method; Ubiquinone; Xanthophylls | 2011 |
2 other study(ies) available for berberine and astaxanthine
| Article | Year |
|---|---|
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
Topics: Adult; Aged; Alleles; Berberine; Cholesterol, LDL; Fatty Alcohols; Female; Heterozygote; Humans; Hypercholesterolemia; Linear Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Serine Endopeptidases; Xanthophylls | 2016 |
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Treatment Outcome; Ubiquinone; Xanthophylls | 2018 |